What is IMRN's relative strength rating?

IMRN ranks at the 46th percentile over 1 month, 70th percentile over 3 months, 88th percentile over 6 months, 20th percentile over 1 year against the full TickerStance CS+ADRC universe of U.S. equities.

What sector is IMRN in?

IMRN is classified under the Healthcare sector within the Pharmaceutical Products industry per the TickerStance sector-classification pipeline, which maps U.S. equities to GICS-aligned sectors using exchange SIC codes and Massive Finance reference data. Healthcare is currently ranked 3 of 11 sectors by relative strength.

Is IMRN in a leading sector?

Yes — Healthcare ranks at the 82th percentile by sector relative strength, placing it in the leading band (≥ 70th percentile). IMRN benefits from positive sector-level momentum, which historically correlates with above-average stock-level RS performance in the O'Neil / Minervini framework.

How volatile is IMRN?

IMRN currently shows a 20-day average daily range (ADR%) of 6.4%, a 90-day beta versus the S&P 500 of 0.84. An ADR% above 4% indicates an intraday swing-trading eligible name in the Minervini Volatility Contraction Pattern framework. ADR% and ATR% are updated daily; beta is computed over a trailing 90-day window.

Does IMRN have a seasonal pattern?

TickerStance computes IMRN's month-by-month seasonality from its full daily price history: the average and median return for each calendar month, how often that month closed higher, and the best and worst months on record. These are historical frequencies, not forecasts — a strong seasonal month describes what IMRN has tended to do in prior years, not a prediction of what comes next. The full month-by-month heatmap and win-rate table sit higher on this page.

When did IMRN last report earnings?

No SEC EDGAR filings are linked to IMRN in the current TickerStance fundamentals database. This can occur for tickers without a matched CIK (some ADRs, ETFs, and recently listed securities) or when the fundamentals pipeline has not yet processed this ticker.

Immuron Limited American Depositary Shares (IMRN)

TODAY'S READ · AS OF 2026-08-24

As of 2026-08-24, Immuron Limited American Depositary Shares (IMRN) has a 3-month relative strength percentile of 70 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 49. The current market Stance is 47.8 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 6.4%, relative volume 0.25×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.

RS methodology →

Market-wide RS; lit = leaderboard

Lenses lit

3 month70pctile

6 month88pctile

1 year20pctile

Classic43IBD pctile

LDR18leadership

0 of 5 lenses lit · avg RS pctile 48

✓ADR%6.4%✓A/DA!RVOL0.25×!$ Vol$42K

Market backdrop

47.8Neutral

Trend30% weight44.9 Breadth30% weight50.6 Leadership20% weight42.4 Macro20% weight59.0 Full stance breakdown →

§ Seasonality

10y · since 2022

Best monthMay on averageavg +13.41% · 40% win · n 5

Worst monthDec on averageavg -19.57% · 0% win · n 4

IMRN monthly seasonality strip
	Jan	Feb	Mar	Apr	May	Jun	Jul	Aug	Sep	Oct	Nov	Dec
1	IMRN Jan avg: 12.95% median: 15.11% win: 75% σ: 10.30% n: 4 2022-04-12 → 2026-07-31	IMRN Feb avg: -11.62% median: -11.17% win: 0% σ: 4.98% n: 4 2022-04-12 → 2026-07-31	IMRN Mar avg: 10.98% median: -1.85% win: 50% σ: 28.07% n: 4 2022-04-12 → 2026-07-31	IMRN Apr avg: 1.00% median: 4.44% win: 60% σ: 10.92% n: 5 2022-04-12 → 2026-07-31	IMRN May avg: 13.41% median: -0.94% win: 40% σ: 35.55% n: 5 2022-04-12 → 2026-07-31	IMRN Jun avg: -10.91% median: -3.81% win: 20% σ: 13.78% n: 5 2022-04-12 → 2026-07-31	IMRN Jul avg: 2.42% median: 2.83% win: 60% σ: 6.65% n: 5 2022-04-12 → 2026-07-31	IMRN Aug avg: 4.54% median: 6.09% win: 75% σ: 8.79% n: 4 2022-04-12 → 2026-07-31 (current)	IMRN Sep avg: -1.83% median: 2.85% win: 75% σ: 11.91% n: 4 2022-04-12 → 2026-07-31	IMRN Oct avg: -12.21% median: -9.71% win: 0% σ: 12.76% n: 4 2022-04-12 → 2026-07-31	IMRN Nov avg: 5.12% median: 3.24% win: 50% σ: 14.40% n: 4 2022-04-12 → 2026-07-31	IMRN Dec avg: -19.57% median: -11.20% win: 0% σ: 24.42% n: 4 2022-04-12 → 2026-07-31

Evidence · 1 of 3

Receipts behind the read

2 of 5 pass

Leadership

Is it leading?

Relative strength across horizons plus the leadership score.

1m

46

3m

70

6m

88

1y

20

LDR

—

StageWeinstein stage analysis

Stage 1 · Basing

Smart money

Who's accumulating?

Accumulation rating, relative volume, U/D ratio, breakout-day proof.

A/D ratingaccumulation / distribution

AAccum

RVOL todayvs 50d avg

0.25×

U/D ratiolast 50 sessions

1.06

Breakout volbreakout day vs 50d avg

-87%

50d avg $ volumeliquidity proxy

$42K

Risk profile

How much does it move?

Daily range, ATR, beta, and the math for a 1-ADR stop.

ADR% (20d)avg daily range

6.4%Elevated

ATR(14)14-day EMA

$0.08

ATR%ATR as % of close

7.18%

Beta vs SPY90d rolling

0.84

1-ADR stoprisk from close $1.12

$1.05−6.4%

Fundamentals · IMRN

Does the business back the chart?

No SEC filings on file for this ticker. Fundamentals section requires EDGAR coverage.

Evidence · 2 of 3

Sector context

Healthcare · 82th pctile in sector

Top peers · Healthcare

Who else is leading?

ELOX
99RS 3m
FBRX
99RS 3m
MRNA
99RS 3m
IMRN
70RS 3m · you

Sector vs market

Healthcare · 3 of 11

Energy100

Technology91

Healthcare82

Financials73

Materials64

Industrials55

Real Estate45

Consumer Staples36

RS pctileLagLead

PEERS · Pharmaceutical Products

Same industry, closest relative strength

4 peers · by RS6M

VORVor Biopharma Inc. Common Stock88 ALLRAllarity Therapeutics, Inc. Common Stock88 DSGNDesign Therapeutics, Inc. Common Stock87 JAZZJazz Pharmaceuticals, Inc.87

Public attention · IMRN

Is the crowd watching?

62/ 100 · vs its own 90-day norm▲ 17 vs 7dLate-cycle leader

Strong relative strength with attention running hot versus its own recent norm. The trend is intact but well-noticed; elevated retail attention has historically been associated with softer forward returns. Context, not a call.

Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.

News

Reference

Company snapshot

SectorHealthcare

IndustryPharmaceutical Products

SIC2834

Floatn/a

Shares out8.1Mshares

Market cap$9.0MNano Cap

FAQ

Frequently asked questions

What is IMRN's relative strength rating?: IMRN ranks at the 46th percentile over 1 month, 70th percentile over 3 months, 88th percentile over 6 months, 20th percentile over 1 year against the full TickerStance CS+ADRC universe of U.S. equities.
What sector is IMRN in?: IMRN is classified under the Healthcare sector within the Pharmaceutical Products industry per the TickerStance sector-classification pipeline, which maps U.S. equities to GICS-aligned sectors using exchange SIC codes and Massive Finance reference data. Healthcare is currently ranked 3 of 11 sectors by relative strength.
Is IMRN in a leading sector?: Yes — Healthcare ranks at the 82th percentile by sector relative strength, placing it in the leading band (≥ 70th percentile). IMRN benefits from positive sector-level momentum, which historically correlates with above-average stock-level RS performance in the O'Neil / Minervini framework.
How volatile is IMRN?: IMRN currently shows a 20-day average daily range (ADR%) of 6.4%, a 90-day beta versus the S&P 500 of 0.84. An ADR% above 4% indicates an intraday swing-trading eligible name in the Minervini Volatility Contraction Pattern framework. ADR% and ATR% are updated daily; beta is computed over a trailing 90-day window.
Does IMRN have a seasonal pattern?: TickerStance computes IMRN's month-by-month seasonality from its full daily price history: the average and median return for each calendar month, how often that month closed higher, and the best and worst months on record. These are historical frequencies, not forecasts — a strong seasonal month describes what IMRN has tended to do in prior years, not a prediction of what comes next. The full month-by-month heatmap and win-rate table sit higher on this page.
When did IMRN last report earnings?: No SEC EDGAR filings are linked to IMRN in the current TickerStance fundamentals database. This can occur for tickers without a matched CIK (some ADRs, ETFs, and recently listed securities) or when the fundamentals pipeline has not yet processed this ticker.

Immuron Limited American Depositary Shares (IMRN) — Stance & relative strength

Lenses lit

Market backdrop

Receipts behind the read

Is it leading?

Who's accumulating?

How much does it move?

Does the business back the chart?

Sector context

Who else is leading?

Healthcare · 3 of 11

Same industry, closest relative strength

Is the crowd watching?

Company snapshot

Frequently asked questions

Immuron Limited American Depositary Shares (IMRN) — Stance & relative strength

Lenses lit

Market backdrop

§ Seasonality

Receipts behind the read

Is it leading?

Who's accumulating?

How much does it move?

Does the business back the chart?

Sector context

Who else is leading?

Healthcare · 3 of 11

Same industry, closest relative strength

Is the crowd watching?

Company snapshot

Frequently asked questions

§ Seasonality

Immuron Limited American Depositary Shares (IMRN) — Stance & relative strength

IMRN is on the watchlist, not confirmed. 3m RS is 70, Market Stance is mixed at 47.8, A/D rating A

Lenses lit

Market backdrop

Receipts behind the read

Is it leading?

Who's accumulating?

How much does it move?

Does the business back the chart?

Sector context

Who else is leading?

Healthcare · 3 of 11

Same industry, closest relative strength

Is the crowd watching?

Company snapshot

Frequently asked questions

Immuron Limited American Depositary Shares (IMRN) — Stance & relative strength

IMRN is on the watchlist, not confirmed. 3m RS is 70, Market Stance is mixed at 47.8, A/D rating A

Lenses lit

Market backdrop

Receipts behind the read

Is it leading?

Who's accumulating?

How much does it move?

Does the business back the chart?

Sector context

Who else is leading?

Healthcare · 3 of 11

Same industry, closest relative strength

Is the crowd watching?

Company snapshot

Frequently asked questions